Loreen Straub, MD MS

Research Fellow
Brigham and Women's Hospital/Harvard Medical School
Cambridge, Massachusetts, United States

Dr. Loreen Straub is a physician by training and a research specialist in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women's Hospital, Harvard Medical School.
Her research focuses on drug safety evaluation from non-randomized data, with a special emphasis on the association between prenatal drug exposure and adverse pregnancy outcomes. She has also particular interest in the advancement of methods to improve utilization of claims databases for epidemiologic research.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Psychostimulant Use During Pregnancy and the Risk of Neurodevelopmental Disorders in Children

  Friday, August 26, 2022
  2:00 PM – 2:15 PM CEST

• Topiramate During Pregnancy and the Risk of Neurodevelopmental Disorders in Children

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST

• Initiation of Atenolol versus Methyldopa During Pregnancy and the Risk of Intrauterine Growth Restriction/small for Gestational Age

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST

• Development and Validation of Claims-based Algorithms for Estimating Gestational Age of Spontaneous Abortion and Termination

  Sunday, August 28, 2022
  8:45 AM – 9:00 AM CEST

• Hierarchical Clustering Analysis to Inform Classification of Congenital Malformations for Surveillance of Medication Safety in Pregnancy

  Sunday, August 28, 2022
  9:15 AM – 9:30 AM CEST